CClinicalTrials.gg
CompletedNCT00592722Updated Jul 3, 2009

A Multi-Centre Clinical Study in Chronic Spinal Cord Injury Patients

An observational study in Spinal Cord Injuries, sponsored by China Spinal Cord Injury Network. Completed at 5 sites in 2 countries. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2009-07-03.

Sponsored by China Spinal Cord Injury Network · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 60 Years
Sex
All
01

Study summary

To establish a solid foundation, e.g. network and a coordinating centre for testing new SCI therapies in forthcoming randomized controlled multi-centre clinical trials following international standards and guidelines

02

Conditions studied

  • Spinal Cord Injuries
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 60 is close to the median of 60 across 323 observational studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

China Spinal Cord Injury Network is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Hospital

Inclusion criteria

  1. Male or female adult subjects, 18 to 60 years of age;
  2. Have a clinical diagnosis of chronic SCI (defined as a history of ≥ 12 months suffering SCI);
  3. The diagnosis of SCI was confirmed by MRI; and
  4. Voluntarily signs and dates an Informed Consent Form, approved by an Institutional Review Board (IRB)/Independent Ethics Committee (IEC), prior to any study-specific procedures

Exclusion criteria

Exclusion Criteria:

  1. Severe head injury;
  2. Is medically or mentally unstable according to the judgement of the Investigator;
  3. History of Multiple Sclerosis or peripheral demyelinating disease;
  4. Likely to have experimental therapy;
  5. Any criteria, which, in the opinion of the investigator, suggests that the subject would not be compliant with the study protocol
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (actual)
06

What researchers measure

Primary outcomes

  1. The primary study outcomes will be the subject recruitment rate, the subject drip out rate, the number of missing values and the number of submitted incorrect values

    Time frame: 6 months

07

Study locations

5 sites
  • First Affiliated Hospital of Fujian Medical University
    Fuzhou, Fujian, China
  • 301 Orthopedic Hospital
    Beijing, China
  • Second Affiliated Hospital of Third Military Medcial University
    Chongqing, China
  • Buddhist Tzu Chi General Hospital
    Hualien, Taiwan
  • China Medical University Hospital
    Taichung, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00592722
Lead sponsor
China Spinal Cord Injury Network
Collaborators
The University of Hong Kong
First posted
Jan 14, 2008
Start date
Dec 2007
Primary completion
Dec 2008
Completion
Mar 2009
Last update
Jul 3, 2009

Study contacts

Wise Young, MD, PhD
study director · The University of Hong Kong

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion